Riyadh Dubai Beirut info@ccho-ma.com
LinkedIn
CCHO – Access to Medicine

Communications and Stakeholder Engagement

Before you make your case to payers, it helps to know what they think. We talk to payers, clinicians and HTA experts to test your assumptions and shape how you engage them.

We gather insight from payers, clinicians and HTA stakeholders through primary research, and turn it into engagement strategies and evidence-based communications. Drug developers use this to test their market access hypotheses, anticipate reimbursement questions and build a stronger value story.

Primary Stakeholder Research

CCHO conducts extensive primary research to gather actionable insights from key payer, clinical, and HTA stakeholders. Our research is designed to uncover deep understanding and nuanced perspectives from payer decision-makers that inform strategic decisions and enhance engagement between drug developers and payers.

Primary research methodologies include:

Telephone interviews
Online surveys
Advisory boards
Delphi panels

Stakeholder Engagement Strategy

Our tailored stakeholder engagement strategies ensure meaningful interactions with key opinion leaders, payers, prescribers, and patients. We design and implement strategies that foster positive relationships, build trust, and drive alignment on key issues.

Using validated cognitive insights approaches, we map stakeholder beliefs and attitudes to understand their decision-making processes and core values and goals. This allows us to develop targeted strategies that address payer concerns and optimize market access and reimbursement outcomes.

Recent Engagements

Patient engagement in HTAA regional consensus with 15 experts from 4 GCC countries, using a one-day workshop and Delphi-style voting. Result: a 4-pillar framework and phased implementation guidance, published as a white paper, abstract and manuscript.
Rare disease payer advisory boardRegulator, payer, pharmacy and clinical perspectives on evidence, pricing and managed entry options, leading to recommendations for a reimbursement submission.
Saudi private-sector innovation accessA policy forum with regulators, insurers, providers, industry and academia, producing a sequenced roadmap and policy report.

Every project is designed around your objectives.

Book a Complimentary Consultation

Tell us about your evidence or access challenge in the MENA region. We reply within two business days.